Drug profile · INN
givinostat hydrochloride
DUVYZAT
givinostat hydrochloride (DUVYZAT) is a histone deacetylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — givinostat hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
givinostat hydrochloride (DUVYZAT) is a histone deacetylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histone deacetylase inhibitor
Primary target: Histone deacetylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is givinostat hydrochloride?
givinostat hydrochloride (DUVYZAT) is a histone deacetylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for givinostat hydrochloride?
DUVYZAT is a marketed brand name for givinostat hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of givinostat hydrochloride?
givinostat hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.